UK consults on removing infringement risks associated with testing patented drugs
This article was originally published in SRA
Executive Summary
The UK's Intellectual Property Office is inviting feedback on proposed changes to the Patents Act that, if implemented, would allow drug makers to carry out clinical and field trials of new drugs without the risk of being sued for patent infringement1.